Member Info for technick

Allah, you said no deformation was intended, but you continue to be disrespectful. Please grow up.

Cwalsh, they won't reply, I am sure they get requests for information every day these days and they'll be weary of releasing information that isn't in the public domain. No news is no news. If there was anything that suggested something wasn't going to pan out as stated to the public, they are legally bound to announce it. Bad news has to be delivered as quickly as good news.

dream what covid stocks are you invested in?

Can we please stop the continual defamation of peoples characters. Shame on you. Use of words like incompetent is incredibly disrespectful to companies and individuals trying to make a difference. Shame on you.

Has anyone tried to value this? 5m a day at full capacity sounds like a large number

It's like listening to the US presidential debate this morning ;)

This is what I like about this business, a number of strings to its bow and what a time to be making 'technical' masks. 5m production capacity a month with a textile that is protected with its own IP and distinct from the competition. Long term value too beyond the current pandemic. Nice.

strategies afoot for sure

to put things into perspective, AVCT director sold £250k worth of shares and it has knocked almost GDRs entire market cap off their share price, strange days

Magsy18, agree :) happy to buy more again when it drops more, it all helps

director sells £250k of shares and wipes £46m off the share price, strange days indeed!

The two companies know each other, they have the same past, surely the approved test Epistem offer as a service is the Genedrive test, even if its under some preferential agreement to share performance data.

Epistem spun out of Genedrive and Genedrive on the same site, I wonder?

https://www.epistem.co.uk/covid/covid-intro.php

BB, nice summary, the other big difference between GDR and NCYT is that they are all about selling to customers, GDR isn't. GDR is about selling to partners who sell to customers. We need the likes of BC or Sysmex to make our market. All of the current tests GDR has for HCV and AIHL go via a commercial partner. Apart from DOD which is direct. I suspect the sysmex and BC are looking for a few very large contracts rather than selling to all comers. It sort of slows the process, regulatory, pitch, then evaluation.

Final results last year were start of October

Trading update shortly, I believe you can delay RNS'ing information if it coincides / is close to the dates a business is due to update the market on substantially similar events. So let's see what the trading update brings us?

DRM, we don't have zero sales, we have sales that don't match your expectations. Everyone is paperless these days, no tree impact.

It was one of the reasons I invested here, no hype, solid board and a really tangible background. It's a hold and build for a few years which should see decent price corrections as mining progresses. As it should be, a good old fashioned investment.

we need a balance in views on this BB for sure, bottom line for me is that clearly process has been hampered but the lack of communication only serves to point to a delay being procedural otherwise they would have to announce reasons. Similarly with sales, there is no doubt some sales happening in the background, the lack of RNS either way suggests that whilst there are no huge sales contracts, sales are consistent with a market perception otherwise again they'd have to RNS, the legalities of when RNS should and shouldn't be released suggest things are progressing

Invest, it shows positive progress for them to change their position on this. It would be highly significant